Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy

Journal of Pediatrics

Volumn 163, Issue 4, 2013, Pages

  Barber, Brent J ^a   Andrews, Jennifer G ^a   Lu, Zhenqiang ^b   West, Nancy A ^c   Meaney, F John ^a   Price, Elinora T ^a   Gray, Ashley ^a   Sheehan, Daniel W ^d   Pandya, Shree ^e   Yang, Michele ^f   Cunniff, Christopher ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Global Health and Health Disparities   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CHILD; CORTICOSTEROID THERAPY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL TIME; TREATMENT DURATION;

EID: 84884673254     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.05.060     Document Type: Article

References (30)

1. J. Ross On a case of pseudo-hypertrophic paralysis Br Med J 1 1883 200 202
2. M. Eagle, S.V. Baudouin, C. Chandler, D.R. Giddings, R. Bullock, and K. Bushby Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation Neuromuscular Disord 12 2002 926 929
3. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy Pediatrics 116 2005 1569 1573
4. J. Finsterer, and C. Stollberger The heart in human dystrophinopathies 692 Cardiology 99 2003 1 19
5. G. Nigro, L.I. Comi, L. Politano, and R.J. Bain The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy Int J Cardiol 26 1990 271 277
6. D. Duboc, C. Meune, G. Lerebours, J.Y. Devaux, G. Vaksmann, and H.M. Becane Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy J Am Coll Cardiol 45 2005 855 857
7. K. Bushby, and R. Griggs 145th ENMC International Workshop: Planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD) October22-24, 2006, Naarden, The Netherlands Neuromuscular Disord 17 2007 423 428
8. K. Bushby, R. Finkel, D.J. Birnkrant, L.E. Case, P.R. Clemens, and L. Cripe Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management Lancet Neurol 9 2010 77 93
9. R.T. Moxley III, S. Ashwal, S. Pandya, A. Connolly, J. Florence, and K. Mathews Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology 64 2005 13 20
10. A.Y. Manzur, T. Kuntzer, M. Pike, and A. Swan Glucocorticoid corticosteroids for Duchenne muscular dystrophy Cochrane Database Syst Rev 1 2008 CD003725
11. L.W. Markham, R.L. Spicer, P.R. Khoury, B.L. Wong, K.D. Mathews, and L.H. Cripe Steroid therapy and cardiac function in Duchenne muscular dystrophy Pediatr Cardiol 26 2005 768 771
12. L.W. Markham, K. Kinnett, B.L. Wong, D. Woodrow Benson, and L.H. Cripe Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy Neuromuscular Dis 18 2008 365 370
13. S. Houde, M. Filiatrault, A. Fournier, J. Dubé, S. D'Arcy, and D. Bérubé Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up Pediatr Neurol 38 2008 200 206
14. B.A. Berko, and M. Swift X-linked dilated cardiomyopathy N Engl J Med 316 1987 1186 1191
15. D. Townsend, S. Yasuda, J. Chamberlain, and J.M. Metzger Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy Trends Cardiovasc Med 19 2009 50 55
16. L.A. Miller, P.A. Romitti, C. Cunniff, C. Druschel, K.D. Mathews, and F.J. Meaney The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology Birth Defects Res A Clin Mol Teratol 76 2006 793 797
17. S.E. Lipshultz, L.A. Sleeper, J.A. Towbin, A.M. Lowe, E.J. Orav, and G.F. Cox The incidence of pediatric cardiomyopathy in two regions of the united states N Engl J Med 348 2003 1647 1655
18. J.L. Jefferies, B.W. Eidem, J.W. Belmont, W.J. Craigen, S.M. Ware, and S.D. Fernbach Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy Circ J 112 2005 2799 2804
19. T. Nagai Prognostic evaluation of congestive heart failure in patients with Duchenne muscular dystrophy - a retrospective study using noninvasive cardiac function tests Jpn Circ J 53 1989 406 415
20. L. Viollet, P.T. Thrush, K.M. Flanigan, J.R. Mendell, and H.D. Allen Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy Am J Cardiol 110 2012 98 102
21. K. Bushby, R. Finkel, D.J. Birnkrant, L.E. Case, P.R. Clemens, and L. Cripe Diagnosis and management of Duchenne muscular dystrophy, Part 2: implementation of multidisciplinary care Lancet Neurol 9 2010 177 189
22. K.M. English, and J.L. Gibbs Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders Dev Med Child Neurol 48 2006 231 235
23. L.W. Markham, E.C. Michelfelder, W.L. Border, P.R. Khoury, R.L. Spicer, and B.L. Wong Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy J Am Soc Echocardiogr 19 2006 865 871
24. K.N. Hor, J. Wansapura, L.W. Markham, W. Mazur, L.H. Cripe, and R. Fleck Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study J Am Coll Cardiol 53 2009 1204 1210
25. C.K. Silversides, G.D. Webb, V.A. Harris, and D.W. Biggar Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy Am J Cardiol 91 2003 769 772
26. G. Schram, A. Fournier, H. Leduc, N. Dahdah, J. Therien, and M. Vanasse All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy J Am Coll Cardiol 61 2013 948 954
27. W.D. Biggar, L. Politano, V.A. Harris, L. Passamano, J. Vajsar, and B. Alman Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 94 Neuromuscular Disord 14 2004 476 482
28. D. Townsend, S. Yasuda, S. Li, J.S. Chamberlain, and J.M. Metzger Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle Mol Ther 16 2008 832 835
29. E.M. Welch, E.R. Barton, J. Zhuo, Y. Tomizawa, W.J. Friesen, and P. Trifillis PTC124 targets genetic disorders caused by nonsense mutations Nature 447 2007 87 91
30. S. Fletcher, K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, and J.P. Steinhaus Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse Mol Ther 15 2007 1587 1592